Biological Markers of Functional Effects of Physical Activity in an

Status Completed

Clinical Trial Summary

Circulating biomarkers are promising tools for the early diagnosis of aging-associated pathologies. Inflammation and immunity are associated with the risk of sarcopenia and frailty in elderly patients. The investigators investigate the effect of an adapted physical activity program on the metabolism and function of circulating immune cells and miRNA in frail and non-frail elderly subjects. Induced immune changes are analyzed together with that of motor abilities and of frailty status.

Clinical Trial Description

Circulating biomarkers are promising tools for early diagnosis of pathologies associated with aging. Inflammation and immunity are associated with the risk of sarcopenia and frailty in elderly patients. The investigators investigate the effect of an adapted physical activity program on the metabolism and function of circulating immune cells and miRNA in frail and non-frail elderly subjects. The main objective is to establish the link between biological markers of aging (immune cells phenotypes and function, miRNA) and motor capacities alteration/improvement. The secondary objectives are: (1) to characterize the functional and immunometabolic dimensions of frailty from objective indicators; (2) to propose a management system through adapted and individualized physical activity, based on objective indicators; (3) to evaluate the clinical impact of both frailty and its preventative management through physical activity; and (4) to identified new biomarkers of frailty. A total of 100 patients categorized as frail, pre-frail, and non-frail after a standardized geriatric evaluation are included in a comparative and interventional study. Exercise intervention consists in a 12-weeks physical activity program. Blood sample and physical/psychological functional measurements are performed before and after the 12-weeks physical activity program. ANOVA tests and correlational analysis will be performed. The finality of the study is to improve the medical prescription of physical activities in elderly patients. ;

Study Design

Related Conditions & MeSH terms

Fragility

Clinical Trial Details

NCT number	NCT04080063
Study type	Interventional
Source	Centre Hospitalier Universitaire de Nice
Contact
Status	Completed
Phase	N/A
Start date	November 4, 2019
Completion date	February 21, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03009851` - Testing the Effectiveness of an Occupation-based Cultural Intervention in Long-term Care	N/A
Recruiting	`NCT04518423` - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
Completed	`NCT02690402` - Fragility and Adapted Physical Activity	N/A
Completed	`NCT04110509` - Fragility and Programmed Cardiovascular Surgery (EcoSarco)
Completed	`NCT03320655` - Effectiveness of Combined Aerobic and Strength Training in Acute and Chronic Adaptations in Patients With Heart Failure	N/A
Active, not recruiting	`NCT01646632` - Exercise Intervention in Institutionalized Elderly People	Phase 2
Completed	`NCT04594655` - MPI Predicts Outcome of CRC Elderly Patients (MPI=MULTIDIMENSIONAL PROGNOSTIC INDEX; CRC=COLORECTAL CANCER)
Active, not recruiting	`NCT06361615` - Effect of a Dual-task Intervention Program on Physical and Cognitive Function	N/A
Completed	`NCT04151732` - Factors Associated With Future Fractures in Middle-aged Men and Women
Completed	`NCT06010069` - The Relationship Between the Frequency of Intraoperative Hypothermia and Fragility Scores
Recruiting	`NCT02952443` - Exercise Intervention to Reverse Frailty	N/A
Recruiting	`NCT04120012` - The Effect of Frailty to Perioperative Complications in the Elderly
Completed	`NCT02772952` - Effectiveness of a Multi-component Physical Training in Hyper-fragile Elders: A Randomized Clinical Trial	N/A
Recruiting	`NCT04092504` - Optimized Recovery After Trauma in Geriatric Patient	N/A
Completed	`NCT03958318` - Multi-component Exercise Program and Nutritional Supplementation in Frail Older Adults	N/A
Recruiting	`NCT05808686` - Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals	Phase 2
Completed	`NCT03246035` - Reducing Readmission for Frail Elderly Patients With Decompensated Heart Failure	N/A
Completed	`NCT03528005` - Effectiveness of Integrated Care Network	N/A
Withdrawn	`NCT02850731` - Motorized Platform and Autonomy Among the Frail and Pre-frail Older Adult (PLATAUTONOMIE)	N/A
Completed	`NCT01706133` - An Intervention for Elderly in Emergency Services	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Biological Markers of Functional Effects of Physical Activity in an Elderly Population — BIO-APAS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms